# Shankar Siva

Source: https://onco.cc/people/shankar-siva/  
OnCo record `shankar-siva` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Radiation oncologist who established stereotactic radiotherapy as a non-surgical option for primary kidney cancer.

## Summary

Shankar Siva led the FASTRACK trials and the International Radiosurgery Oncology Consortium for Kidney pooled analyses showing stereotactic ablative body radiotherapy achieves near-complete local control of primary renal cell carcinoma in patients unfit for surgery, and leads TROG trials of SABR in oligometastatic prostate and lung cancer and of radiotherapy-immunotherapy combinations. He chairs the TROG genitourinary group.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: radiotherapy; sbrt; kidney; australia
- Role: Professor and Director of Radiation Oncology Research, Peter MacCallum Cancer Centre
- Specialisms: Stereotactic radiotherapy; Kidney cancer; Oligometastatic disease; Radiotherapy-immunotherapy combinations

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Siva%20S%5BAuthor%5D%20stereotactic%20kidney

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/), [Renal cell carcinoma](https://onco.cc/cancers/rcc/)
- technologies: [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- companies: [TROG Cancer Research](https://onco.cc/companies/trog/)
- institutions: [Peter MacCallum Cancer Centre](https://onco.cc/institutions/peter-mac/)

---
JSON: https://onco.cc/api/v1/entities/shankar-siva.json